ESOC 2024 | ESOC 2024: growing focus on ICH

Raffaele Ornello, MD, University of L’Aquila, L’Aquila, Italy, highlights the growth in data on intracerebral hemorrhage in recent years, with ICH management strategies representing a significant focus at ESOC 2024. The conference also focused on the advancements in ischemic stroke treatment, particularly the potential of tenecteplase to replace alteplase as a more effective thrombolytic agent. This interview took place at the 10th European Stroke Organisation Conference (ESOC) 2024 in Basel, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.